Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT
Cited by 116
Related Papers
Lactate Modulates Cellular Metabolism Through Histone Lactylation-Mediated Gene Expression in Non-Small Cell Lung Cancer
|Frontiers in Oncology|2021|251
Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration
|Clinical Cancer Research|2018|97
Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis
|Oncotarget|2016|66
The HIF/PHF8/AR axis promotes prostate cancer progression
|Oncogenesis|2016|59